Results

Total Results: 2,207 records

Showing results for "drug".

181. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
     August 01, 2016 - Food and Drug Administration for AUD include acamprosate (Campral®, thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD.

182. 1. Which patients benefit the most from MTM services? 1.1. Which factors, or combinations of factors, are most predictive of the clinical benefit of MTM services? 1.1.1. Disease factors (e.g., diabetes vs COPD ; multi-morbidity vs single… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-di
     November 01, 2017 - 2.2.What is the optimal timing of MTM services relative to events or diagnosis (e.g., initiation of drug … beneficiaries with 2 or more chronic conditions and high drug expenditures. … Appropriateness for EHC Program Does your question include a health care drug, intervention, device … therapy by including provisions for medication therapy management (MTM) within the Medicare Part D drug … current eligibility criteria limit the inclusion of patients to those with multi-morbidity and high drug

183. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
     June 01, 2018 - Currently, there are no medications approved by the Food and Drug Administration for the prevention … antipsychotic drugs cannot be isolated. 7 Comparison • For KQ 1, we will include non-drug … • For KQ 2, we will include non-drug approaches to treating delirium, including placebo, active … Non-drug interventions will be categorized following the scheme developed by Oh and colleagues.19 … Does antipsychotic drug use increase the risk of long term mortality?

184. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - drug- name=orkambi. 14. Walker J. FDA panel backs Vertex cystic-fibrosis drug Orkambi. … drug-name=orkambi http://www.wsj.com/articles/fda-panel-backs-vertex-cystic-fibrosis-drug-orkambi-1431462559 … Policy #DRUG.00080. [internet]. … drug- name=pirfenidone. 71. Medica. … National drug list: drug list - three (3) tier drug plan.

185. S143 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - Chief among them is the indication for the drug—a patient must have the condition for which the drug … In a randomized drug trial, the allocation of subjects to treatment and control groups at random leads … Seeger, PharmD, DrPH, Ingenix i3 Drug Safety, 950 Winter Street, Suite 3800, Waltham, MA 02451. … by a text search for the drug name. … Drug treatment of lipid disorders. N Engl J Med. 1999;341: 498–511. 6.

186. Migraine Protocol-Appendix 20111103 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
     November 03, 2011 - Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-2 Drug … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-3 Drug … drug management.mp. 2. exp patient care team/ 3. exp delivery of health care, integrated/ 4. … drug surveillance.mp. 10. exp drug monitoring/ 11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10

187. Medicamentos para tratar el trastorno por consumo de alcohol: Revisión de la investigación para adultos (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_espanol.pdf
     November 01, 2016 - � Acamprosato (Campral®): Este medicamento fue aprobado por la Food and Drug Administration (FDA,

188. S44 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug … We simplified the PRT strategy by using designed delays (DD) to evaluate drug policies. … covering the elderly, the poor, and families with high drug expenditures, introduced a drug benefit … Periodic letters on evidence- based drug therapy improves prescribing: a randomized trial. … Randomized controlled trial of a drug policy change by British Columbia PharmaCare.

189. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - Naltrexone/bupropion combination drug is an oral, sustained-release drug intended to fight the body's … Food and Drug Administration (FDA). … Pharmaceutical companies struggle to develop a drug to treat obesity. … Lorcaserin: FDA issues complete response letter for Lorcaserin new drug application. … FDA accepts new drug application filing for Qnexa. [internet].

190. Making Healthcare Safer IV: Use of Report Cards and Outcome Measurements To Improve the Safety of Surgical Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mhs4-surgical-report-cards/research
     February 01, 2024 - Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … Healthcare Safer IV: Opioid Stewardship Rapid Evidence Product | Jan 16, 2024 Reducing Adverse Drug … | Feb 9, 2024 Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug

191. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Tufts University Boston, MA Katharine Lillie, MD Center for Drug Evaluation & Research, Food & Drug … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s … (drug-drug interactions) In August 2012, FDA reported an association between Lovaza and recurrent … Clinical or intermediate harms with cardiovascular drug(s) plus supplement versus drug(s) plus placebo … Pharmacokinetic outcomes with cardiovascular drug(s) plus supplement versus drug(s) plus placebo, no

192. Summary Variables in Observational Research: Propensity Scores and Disease Risk Scores | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/observational-research-scores/research
     January 01, 2019 - If a patient has high cholesterol and is on other medications, then the potential for drug-drug interactions … For example, perhaps an adverse effect of a drug is only apparent when the drug is prescribed to people … Pharmacoepidemiol Drug Saf 2005;14:S22-3. Figure 5. … Pharmacoepidemiol Drug Safety 2005;14(7):465-76. … Pharmacoepidemiol Drug Saf 2005;14:S21.

193. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. … Vertex's two-drug cystic fibrosis treatment shows promise. [internet]. … FDA panel backs Vertex cystic-fibrosis drug Orkambi. Wall Str J. 2015 May 12. … National drug list: drug list - three (3) tier drug plan. … HealthPartners PreferredRx: preferred drug list (formulary). [internet].

194. Patient Safety | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/patient-safety
     January 16, 2025 - Medication Harms in Older Adults Rapid Evidence Product January 16, 2024 Reducing Adverse Drug … September 29, 2023 Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … September 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug

195. Patient Safety | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/patient-safety?page=0
     January 16, 2025 - Medication Harms in Older Adults Rapid Evidence Product January 16, 2024 Reducing Adverse Drug … September 29, 2023 Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … September 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug

196. Pulmonary Arterial Hypertension: Screening, Management, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research
     December 01, 2019 - Thirty-seven studies involving 4,192 patients assessed the effectiveness of drug treatments for PAH in … All drug classes demonstrated increases in 6WMD when compared with placebo, but comparisons between agents … Each drug class showed a favorable impact on at least two of the three hemodynamic outcomes: cardiac … Comparisons of different drug combinations were inconclusive regarding a mortality reduction but suggested … an improvement in 6MWD when a second drug was added to existing monotherapy.

197. Comparative Effectiveness and Safety: Emerging Methods - Part I | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/safety-emerging-methods/overview
     November 01, 2017 - Designed Delays Versus Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug … Developing Indicators of Inpatient Adverse Drug Events Through Nonlinear Analysis Using Administrative … Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug … Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug

198. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Opioid abuse is one of the most common forms of prescription drug abuse. … The company submitted a new drug application to the U.S. … Food and Drug Administration (FDA) in October 2012. … Anonymous and free prescription drug drop off program. [internet]. … Project Lazarus: an innovative community response to prescription drug overdose.

199. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
     October 01, 2015 - the drug cost. … In November 2014, the company submitted a new drug application to the U.S. … Early success for Kalydeco is just the beginning for Vertex's CF drug. … Food and Drug Administration (FDA). … Vertex's two-drug cystic fibrosis treatment shows promise. [internet].

200. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-update/research
     December 01, 2019 - through April 2010 for original English-language articles and sought unpublished data from the Food and Drug … Two-drug combinations had similar HbA1c reduction. … Comparisons of two-drug combinations showed little to no difference in HbA1c reduction, but some combinations … Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug